Contact information
Kelly Davies
BSc
Researcher, Vascular Overviews Group
Kelly joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 2006 initially working on large leukaemia trials such as UKALL XII and CLL4, moving on to the Vascular Overviews Group (VOG) in 2010.
She now works on large-scale meta-analyses such as those conducted by the Antithrombotic Treatment Trialists’ (ATT) and the Cholesterol Treatment Trialists’ (CTT) Collaborations.
Kelly has a degree in Nutrition and Food Science from the University of Surrey (1996) and worked as an analytical chemist for 10 years she completed a postgraduate certificate in epidemiology.
Recent publications
-
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319
-
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A. et al, (2022), Lancet
-
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
BAIGENT C. et al, (2022), The Lancet
-
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials
-
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B. et al, (2018), Lancet Gastroenterol Hepatol, 3, 231 - 241